Both in Pharmaceuticals
Impact BioMedical vs Veru
Over the past year IBO returned −40.2% and VERU returned −16.9%; their daily moves had a correlation of 0.04.
IBO −40.2% VERU −16.9%Growth of $1, one year, split-adjusted
| Metric | IBO | VERU |
|---|---|---|
| Price | $4.02 | $2.16 |
| Market cap | $34.3M | $36.8M |
| Today | +0.25% | 0.00% |
| 1 month | −16.9% | −15.3% |
| 6 months | −50.5% | −2.3% |
| Year to date | −36.9% | +0.9% |
| 1 year | −40.5% | −26.8% |
| Revenue growth (YoY) | −57.1% | — |
| Gross margin | −533.3% | — |
| Net margin | −23300.0% | — |
| P/E (TTM) | 43.5× | — |
| Price / sales | 981.3× | — |
| Net cash | $10.0K | $25.8M |
| Dividend yield | — | — |
| Volatility (60d) | 736.6% | 52.5% |
| Short % of float | 2.6% | 10.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).